Early retinal and retinal nerve fiber layer effects of hydroxychloroquine: A follow up study by sdOCT

Cutaneous and Ocular Toxicology

Volumn 32, Issue 3, 2013, Pages 204-209

  Yülek, Fatma ^a   Uǧurlu, Nagihan ^a   Akçay, Emine ^a   Kocamiş, Sücattin Ilker ^b   Gerçeker, Sidika ^a   Erten, Şükran ^a   Midillioǧlu, Inci ^d   Şimşek, Şaban ^c  

^a YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^b Ardahan State Hospital   (Turkey)

^c MALTEPE UNIVERSITY   (Turkey)

^d NONE

Author keywords

Hydroxychloroquine; Optic coherence tomography; Retinal nevre fiber layer

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; ADVERSE OUTCOME; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; DRUG SAFETY; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; MALE; NERVE CELL; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; RETINA FOVEA; RETINA NERVE CELL; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL THICKNESS; RETINOPATHY; VISUAL FIELD;

ANTIMALARIALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHLOROQUINE; MALE; NERVE FIBERS; RETINA; RETINAL DISEASES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84882979335     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2012.751602     Document Type: Article

References (14)

1. Mavrikakis I, Sfikakis P, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: A reappraisal. Ophthalmology 2003;110:1321-5
2. Marmor MF, Kellner U, Lai TY, et al. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophtalmology 2011;118:415-22
3. Lee AG. Hydroxychloroquine screening. Br J Ophthalmol 2005; 89:521-2 (Pubitemid 40569698)
4. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-81 (Pubitemid 21917444)
5. Stepien KE, Han DP, Schell J, et al. Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss. Trans Am Ophthalmol Soc 2009;107:28-33
6. Korah S, Kuriakose T. Optical coherence tomography in a patient with chloroquine-induced maculopathy. Indian J Ophthalmol 2008;56:511-13
7. Rodriguez-Padilla JA, Hedges 3rd TR, et al. High-speed ultrahigh-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 2007;125:775-80 (Pubitemid 46919738)
8. Turgut B, Türkçüoǧlu P, Serdar Koca S, Aydemir O. Detection of the regression of hydroxychloroquine retinopathy in optical coherence tomography. Clin Rheumatol 2009;28:607-9
9. Kellner S, Weinitz S, Kellner U. Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol 2009; 93:1444-7
10. Lyons JS, Severns ML. Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: A review. Review of mfERG ring ratios in Plaquenil toxicity. Doc Ophthalmol 2009; 118:29-36
11. Chang WH, Katz BJ, Warner JE, et al. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Retina 2008;28:1478-86
12. Rosenthal AR, Kolb H, Bergsma D, et al. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 1978;17:1158-75 (Pubitemid 9030521)
13. Ramsey MS, Fine BS. Chloroquine toxicity in the human eye. Histopathologic observations by electron microscopy. Am J Ophthalmol 1972;73:229-35
14. Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye (Lond) 2010;24:340-6